Grey_Ghost
2 minutes ago
The 8-K makes it clear what the funds will be used for.
Item 1.01. Entry into a Material Definitive Agreement.
Loan Entered Into
On October 31, 2024, Northwest Biotherapeutics, Inc. (the “Company”) entered into a Convertible Note (the “Loan Agreement”)